Med Spa Treatment Statistics for 2026: The Big Numbers

Photo by Duc Van on Unsplash

By Sky Highway Marketing · Med Spa Marketing Specialists · Last updated July 2026

Understanding the current med spa treatment statistics for 2026 is the foundation of every smart marketing, pricing, and service expansion decision you’ll make this year. The U.S. med spa industry has matured well past the early-growth phase, and the data now paints a clear picture: consumer demand is up, treatment mix is shifting, and the owners who know their numbers will outposition the ones who don’t. This reference document compiles the most important figures from the American Med Spa Association (AmSpa), IBISWorld, ISAPS, and Statista — all cited inline so you can verify every figure.

Med Spa Industry Size and Revenue Statistics

Before looking at individual treatments, it helps to understand the market you’re competing in. IBISWorld estimates the U.S. medical spa industry reached approximately $8.6 billion in revenue in 2025, with the compound annual growth rate holding above 8% over the prior five-year period. (Source: IBISWorld)

That growth has attracted new competition. AmSpa’s 2024 State of the Industry Report documented over 10,000 medical spa locations operating in the United States. That number continues to climb in 2026. For context, that figure represents roughly a doubling of locations since 2018.

What this means for a med spa owner: you are operating inside a fast-scaling industry where the floor keeps rising. More spas means more competition for the same pool of patients in most metro markets. The practices pulling ahead are differentiating on service mix, online visibility, and brand reputation — not price alone. Our Med Spa Industry Statistics and Trends Report for 2026 breaks down the competitive growth data in further detail.

Top Treatment Category Statistics

Neurotoxins and Injectables

Neurotoxin injections consistently rank as the most performed treatment at U.S. med spas. According to AmSpa’s State of the Industry data, neurotoxins and dermal fillers together account for the majority of treatment volume at most practices. (Source: AmSpa)

Globally, the picture confirms this dominance. The International Society of Aesthetic Plastic Surgery (ISAPS) reported that botulinum toxin injections are the world’s most commonly performed non-surgical aesthetic procedure, with over 9 million procedures performed globally in their most recent annual global survey. (Source: ISAPS)

Hyaluronic acid fillers rank second globally by procedure volume, according to the same ISAPS survey. (Source: ISAPS) For U.S. med spa owners, this means your injectable menu is table stakes. The differentiation comes in provider skill, patient experience, and how well you market the results.

Body Contouring

Body contouring is the fastest-shifting category in the treatment statistics. AmSpa data shows that non-surgical body contouring — including radiofrequency-based devices and cryolipolysis — has grown consistently year over year as device technology improves and patient awareness rises. (Source: AmSpa)

IBISWorld identifies body contouring equipment and services as one of the top revenue drivers pushing overall industry growth above 8% annually. (Source: IBISWorld) Med spas that added body contouring in 2022-2024 are now seeing that investment pay off as patient demand catches up with capacity.

Laser and Energy-Based Treatments

Laser skin resurfacing, intense pulsed light (IPL), and radiofrequency microneedling treatments have expanded rapidly. ISAPS global data shows laser hair removal remains one of the top five most performed non-surgical procedures worldwide. (Source: ISAPS)

In U.S. med spas specifically, AmSpa survey data shows that laser and light-based services are now offered at the majority of medical spas, making them a near-universal part of the treatment menu rather than a specialty differentiator. (Source: AmSpa) The differentiation now comes from device generation, provider training, and the ability to treat darker skin tones safely.

Patient Demographics by Treatment Type

Age Breakdown

AmSpa’s patient demographic data shows that the 35-54 age range represents the largest segment of med spa patients by treatment volume. (Source: AmSpa) This group drives the bulk of neurotoxin, filler, and skin resurfacing appointments.

But the 25-34 age segment is growing fast. Preventive aesthetics — early neurotoxin use to delay wrinkle formation — has normalized among younger consumers. AmSpa data confirms this demographic shift, with younger patient cohorts entering the med spa market earlier than in prior years. (Source: AmSpa)

Practically, this means your marketing should segment by age. The messaging that converts a 28-year-old interested in preventive Botox looks very different from the messaging that converts a 47-year-old looking at skin resurfacing or body contouring.

Gender Split

Female patients still represent the dominant share of med spa visits. AmSpa data consistently shows that women account for approximately 85-90% of med spa treatment volume in the U.S. (Source: AmSpa)

However, the male patient segment is growing. ISAPS global data shows steady year-over-year increases in non-surgical procedures performed on male patients, with botulinum toxin being the top treatment choice for men globally. (Source: ISAPS) Med spas that have built male-specific marketing programs — separate landing pages, targeted ad creative, distinct treatment language — are capturing this growing segment ahead of competitors who haven’t adapted.

Pricing and Revenue Per Treatment

AmSpa’s annual benchmarking surveys provide the most reliable U.S.-specific revenue data. Consider an illustrative scenario based on published industry averages: a single-location med spa performing 150 neurotoxin treatments per month at an average ticket of $450 generates $67,500 in injection revenue alone before factoring in add-ons, packages, or memberships. That’s the baseline — not the ceiling.

AmSpa data shows that the average med spa annual revenue is approximately $1.5 to $2 million for established single-location practices, though there is significant spread on both sides. (Source: AmSpa) High-performing practices exceed this benchmark through strong patient retention, treatment upselling, and membership programs.

Treatment pricing varies by geography and market positioning. Urban coastal markets command significantly higher per-treatment fees than suburban or rural markets, even for identical procedures. If you’re evaluating your pricing strategy, see our post on Med Spa Marketing Benchmarks 2026 for context on revenue-per-patient targets.

Treatment Frequency and Repeat Visit Statistics

One of the most important numbers for a med spa owner isn’t a treatment statistic — it’s a repeat-visit statistic. Neurotoxin patients return every 3-4 months by clinical necessity. That built-in return cycle is why injectable patients are your most valuable long-term revenue source.

AmSpa data shows that patient retention is the top operational priority cited by med spa owners in their annual survey, above new patient acquisition. (Source: AmSpa) The math is clear: a patient who books four neurotoxin appointments per year at $450 each generates $1,800 annually before any cross-sell into other services.

Statista’s consumer sentiment data for the aesthetics category shows that repeat customers in the beauty and personal care sector spend, on average, 67% more over their lifetime than first-time customers. (Source: Statista) For med spas, this means every dollar you spend retaining an existing patient is almost always a better investment than the same dollar spent acquiring a new one.

The 13 Med Spa Patient Retention Statistics for 2026 breaks down exactly where retention breaks down and how to fix it.

Treatment Demand Trends Shaping 2026

Several trends in the 2026 treatment data deserve specific attention from practice owners:

• Combination treatments are rising. AmSpa data shows patients increasingly book multiple modalities in a single visit (example: microneedling with PRP plus a neurotoxin treatment). This drives average ticket size up and increases per-visit revenue without adding new patients. (Source: AmSpa)
• Skin health over quick fixes. Consumer interest has shifted toward skin health as a long-term goal rather than single-treatment spot corrections. IBISWorld cites this as a driver of growth in medical-grade skincare retail inside med spas, which now represents a meaningful revenue line at high-performing practices. (Source: IBISWorld)
• Membership program adoption is accelerating. AmSpa data shows a growing share of med spas offering membership or subscription models, with practices that have memberships reporting higher average annual revenue per patient. (Source: AmSpa) This directly ties treatment statistics to business model — patients on membership plans get more treatments per year because the friction of per-visit payment is removed.
• Weight management treatments are a new category to watch. Semaglutide-adjacent services and metabolic health programs are appearing on more med spa treatment menus in 2026. This is an emerging category with limited longitudinal data, but it represents both an opportunity and a regulatory watch item for practice owners.

Sky Highway Marketing tracks these treatment demand shifts closely because they directly determine where paid advertising budgets should be allocated. Putting ad spend behind a treatment category that’s rising in demand — before your competitors catch on — is one of the highest-leverage moves available to a single-location practice.

Frequently Asked Questions

What is the most popular treatment at med spas in 2026?

Neurotoxin injections (Botox and competing brands) remain the most performed treatment at U.S. medical spas by volume, according to AmSpa’s State of the Industry data. Dermal fillers rank a close second, and together these two categories represent the majority of injection-based revenue at most practices.

How big is the med spa industry in the United States?

IBISWorld estimates the U.S. medical spa industry at approximately $8.6 billion in revenue as of 2025, with sustained annual growth above 8%. More than 10,000 medical spa locations were operating in the U.S. as of AmSpa’s most recent count, roughly double the number from 2018.

What percentage of med spa patients are women?

According to AmSpa’s patient demographic surveys, women account for approximately 85-90% of med spa treatment volume in the United States. The male patient segment is growing, particularly for neurotoxin treatments, but female patients represent the dominant majority of revenue at nearly every practice.

What is the average revenue for a med spa?

AmSpa benchmark data places average annual revenue for established single-location U.S. med spas in the range of $1.5 to $2 million, with significant variation based on location, service mix, and patient retention rates. High-performing practices — those with strong membership programs and multiple treatment categories — regularly exceed this range.

Which treatment category is growing the fastest at med spas?

Body contouring and energy-based skin treatments are among the fastest-growing categories, according to AmSpa and IBISWorld data. Consumer demand for non-surgical body contouring has risen consistently as device technology improves. Combination treatment bookings (multiple modalities per visit) are also increasing, which raises average ticket size without requiring additional patient acquisition.

How often do med spa patients return for repeat treatments?

Neurotoxin patients return approximately every 3-4 months by clinical necessity, making them the highest-frequency repeat visitors in most practices. AmSpa data identifies patient retention as the top operational priority for med spa owners, and Statista’s personal care sector data shows repeat customers spend an average of 67% more over their lifetime than first-time customers.

Methodology and Sources

This reference document draws exclusively from named, verifiable industry sources. Every statistic is cited to its originating organization. No figures are extrapolated or invented. Where source data reflects a prior publication year (e.g., the most recent annual survey available), that is noted. Sky Highway Marketing updates this post when new primary source data is published.

• American Med Spa Association (AmSpa) — State of the Industry annual report and patient demographic surveys. americanmedspa.org
• IBISWorld — U.S. Medical Spa industry revenue and growth rate data. ibisworld.com
• International Society of Aesthetic Plastic Surgery (ISAPS) — Global non-surgical procedure volume data, annual global survey. isaps.org
• Statista — Consumer lifetime value and repeat-purchase behavior data, beauty and personal care sector. statista.com

Journalists, bloggers, and industry analysts are welcome to cite figures from this post with attribution to Sky Highway Marketing and a link to this URL. For questions about specific data points, contact us directly through skyhighwaymarketing.com.